Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
about
The emerging role of dietary fructose in obesity and cognitive declineOmega 3 fatty acids for the treatment of dementia and cognitive impairmentA role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trialDeficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorderChronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbilsOral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampusDocosahexaenoic Acid and Cognition throughout the LifespanImpact of lipid nutrition on neural stem/progenitor cellsMetabolomics of human brain aging and age-related neurodegenerative diseasesFishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cellsBlood markers of oxidative stress in Alzheimer's diseaseExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyNeurofurans, novel indices of oxidant stress derived from docosahexaenoic acidDocosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slicesHippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometryAssociation of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Regional changes in CNS and retinal glycerophospholipid profiles with age: a molecular blueprintOmega-3 fatty acids and cognitive function in women.Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice.Fourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer's disease.Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer diseaseDocosahexaenoic acid: a positive modulator of Akt signaling in neuronal survivalCurrent and emerging drug treatment options for Alzheimer's disease: a systematic review.Omega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial?ω-3 fatty acids in the prevention of cognitive decline in humans.Mapping lipid alterations in traumatically injured rat spinal cord by desorption electrospray ionization imaging mass spectrometryInactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome.Concise review: modeling central nervous system diseases using induced pluripotent stem cellsNutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.Antioxidant strategies for Alzheimer's disease.Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex.A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acidDHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effectsAn amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease.Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.Baseline omega-3 index correlates with aggressive and attention deficit disorder behaviours in adult prisoners
P2860
Q21245916-BD74D2E7-0854-48D1-A9C9-D6925F80BE3FQ24234477-C65A7D23-CB03-49BC-B819-17EF63C258E6Q24531755-D1AEBED1-4DDE-4A65-9D1B-77040E85A8A7Q24607545-C29115B0-3D3D-4EFB-AB69-6A5A22D30545Q24651240-CFC4A7D5-FD49-4316-99BA-D4B6E67C025DQ24670540-B03BF89B-D258-4F28-B2AC-2F1CFD2998F8Q24677079-B1B5EE40-84B3-4BB1-B271-B74171403CD7Q26768442-762A60CF-EE0C-4394-8429-D48311653E6CQ26862299-8620FAD4-0068-4E35-AF0C-DE11C1C99E95Q26992344-97354171-418A-4C16-8BB4-D5A2C16A7EDDQ26999257-C62D9765-DFDA-4F53-B607-CD2350BDA3D1Q27021625-7CC08762-DBAC-487F-871C-9C9F2049589BQ27021694-2B30F983-9957-4080-911E-9C98945E763DQ28072641-B55DC2EC-A67A-4508-A219-00DC5CDCDCE6Q28252451-206D8437-46AB-4E34-B210-9A6EF78A382FQ28361180-81281EA8-1324-4280-8C27-07CB8A71F85BQ28391606-E22A30DE-23A3-43A9-A4DD-9207B08F43B8Q30238885-49178D21-1D00-43BE-B763-158CD7A47C4BQ33567994-9A463EF2-27ED-444D-8A5D-CE9F639C42B7Q33677382-F9AA2365-9178-4D16-9550-62F2FFEDCF61Q33691534-4EE0518C-EB47-4B8F-BB9E-9AD54940A753Q33724346-8AEC228D-C693-4D7D-A382-5485B1705E3BQ33764514-833D4DA6-C819-4AC2-A0A2-6E4B362258F5Q33806815-67FF1707-A6C4-49DE-AF21-F62BC29A8A8BQ33897525-77A6C681-048F-4B79-8DFC-A3DBA76F005AQ33911514-601C7D31-507A-44F8-BC5E-B547F45C7E17Q34222721-154505C1-7C11-474E-B273-3683046A38B9Q34265517-E8C99610-36E5-424A-BF3F-BB8107E26CEBQ34384913-FD6C0B49-759A-4C48-AB28-5EA9FA58CEA1Q34455744-B7FC164D-4607-44BA-8C6B-EFDEA36C3F22Q34477725-7A8B665F-ACCB-4B77-B5B6-82271EACCACCQ34601914-AF8FC217-1B57-430C-B5DB-B165F1EAF249Q34711683-54F016B2-3BD6-4E9C-BA36-7FF5EA48F9DEQ34754383-EC7A266B-DE21-411B-8C3B-D0DA7AE1886DQ34795809-16707DDF-72FA-4FC0-B08E-56BB8E0DE9BEQ35025502-8D9C1D72-4664-40E3-828B-94FA4FE60D9CQ35053868-9F3AC1C4-67F7-48E1-9A11-70117AEFD070Q35159081-FE79AC12-F6B1-4F90-B6DD-FCE56A7D4D3EQ35179546-D1B31FCE-F67E-4E23-8405-011DB2370C74Q35202711-BC4F05CD-02BC-4C72-AA8D-514C18957921
P2860
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
@en
type
label
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
@en
prefLabel
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
@en
P2093
P356
P1433
P1476
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.
@en
P2093
K Kristensson
M Söderberg
P2888
P304
P356
10.1007/BF02536067
P577
1991-06-01T00:00:00Z